Emélie Braschi

Sep 13, 2024 | cfp.ca | Emélie Braschi |Jennifer Young |G. Michael Allan

Clinical questionWhat are the risks and benefits of using topical corticosteroids for atopic dermatitis in children and adults? Bottom lineWhile evidence is limited, topical steroids are effective against atopic dermatitis and efficacy likely increases with potency. Use once daily seems as effective as twice daily. Treatment 2 days per week of areas with frequent recurrent flares will help about 60% avoid a flare versus about 30% using a placebo over 16 weeks.

Sep 13, 2024 | cfp.ca | Emélie Braschi |Jennifer Young |G. Michael Allan

Question cliniqueQuels sont les risques et les bienfaits d’utiliser des corticostéroïdes topiques pour la dermatite atopique chez les enfants et les adultes? RésultatsBien que les données probantes soient limitées, les corticostéroïdes topiques sont efficaces contre la dermatite atopique, et leur efficacité augmente probablement en fonction de leur puissance. L’application 1 fois par jour semble aussi efficace que l’application 2 fois par jour.

Aug 9, 2024 | cfp.ca | Emélie Braschi |Samantha Moe

Clinical questionDo self-fitted hearing aids improve hearing for adults with mild to moderately severe hearing loss? Bottom lineSome, not all, direct-to-consumer (DTC) self-fitted hearing aids are likely comparable to audiogram-fitted conventional hearing aids and tend to cost less. EvidenceConventional hearing aids are adjusted to patients’ specific hearing characteristics using an audiogram. For DTC hearing aids, patients used smartphone applications or preprogrammed settings to self-fit them.

Nov 14, 2023 | cfp.ca | Emélie Braschi |Samantha Moe

Clinical questionWhat are the risks and benefits of using topical calcineurin inhibitors for atopic dermatitis? Bottom lineFor improvement of atopic dermatitis, 0.1% tacrolimus ointment is at least equivalent to moderate-potency topical corticosteroids. Use of 1% pimecrolimus cream is better than placebo but is likely inferior to 0.1% tacrolimus ointment and moderate-potency corticosteroids.

Mar 21, 2023 | cfp.ca | Samantha Moe |G. Michael Allan |Emélie Braschi

Research ArticleTools for Practice Canadian Family Physician 69 (3) 180; DOI: https://doi.org/10.46747/cfp.6903180 Clinical questionDo bronchodilators or inhaled corticosteroids (ICS) help postinfectious cough (PIC) in adults without asthma? Bottom lineData are limited, with results from only 2 ICS RCTs and 1 bronchodilator RCT.